This session focuses on one of the most critical, yet often underestimated, aspects of MedTech product development: validation and regulatory readiness. From sterilization and cleaning validation to meeting key compliance milestones, early-stage innovators face a complex landscape that can make or break their path to market.

We will offer practical insights on how startups can build robust testing strategies, prepare for regulatory reviews, and avoid costly setbacks during product development. We’ll explore how to integrate validation early, collaborate effectively with testing labs, and align with evolving global standards.
Whether you're designing your first clinical device or scaling up for commercialization, this session will help you better understand the technical and regulatory hurdles that shape MedTech success.

Guest Speaker:
We’re excited to welcome Dr. Anas Aljabo, Co-Founder and Executive Vice President of SteriLabs, an ISO/IEC 17025-accredited laboratory supporting medical device testing and validation. He also serves as Director of R&D at SteriPro, a leading Canadian provider of reprocessing services for hospitals and clinics.

With over a decade of experience across biotech, research, and medical device development, Dr. Aljabo specializes in helping innovators navigate sterilization, validation, and compliance. His active involvement in standards bodies such as SCC, AAMI, and ASTM, combined with a PhD in Biomaterials and Tissue Engineering from UCL, makes him a vital voice in bridging academic rigor with industrial application.

Join us on November 27th, 2025 at 6:00 PM for this virtual session, as Dr. Aljabo shares real-world insights on overcoming the “validation gap” and bringing safe, effective MedTech products to market.

Be part of the conversation driving innovation and regulatory excellence in Canadian health technology.